Search - tctmd.com

Displaying 121 - 140 of 163

Sort: Relevancy | Date

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

News Industry News

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

December 07, 2015

News Industry News

ArtVentive Medical Begins Testing the Next Generation of its EOS™ Technology

December 02, 2015

News Industry News

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

November 30, 2015

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

Presentation Aortovascular 2015

Novel Anticoagulants for Venous Thromboembolism: Will this change your practice?

Presenter: Michael R. Jaff

September 18, 2015

News Industry News

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

August 06, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Industry News

UK launch for Daiichi's bloodthinner Lixiana

July 10, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

Presentation CCVVC 2015

Thrombolysis In Acute Limb Ischemia

Presenter: Ravish Sachar

June 18, 2015

Presentation CCVVC 2015

Endovascular Treatment of DVT

Presenter: Felipe Navarro

June 18, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

Presentation CADECI 2015

NOAs for the treatment of venous thromboembolism

Presenter: Giancarlo Agnelli

February 19, 2015

News Daily News

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

February 03, 2015

News Daily News

Narrowing Coronary Sinus May Provide Relief From Refractory Angina

Todd Neale

February 03, 2015

Advertisement

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

ArtVentive Medical Begins Testing the Next Generation of its EOS™ Technology

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

Novel Anticoagulants for Venous Thromboembolism: Will this change your practice?

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

肺栓塞发作后，二级抗凝效果未持续

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

UK launch for Daiichi's bloodthinner Lixiana

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

Thrombolysis In Acute Limb Ischemia

Endovascular Treatment of DVT

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

NOAs for the treatment of venous thromboembolism

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

Narrowing Coronary Sinus May Provide Relief From Refractory Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content